These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2963759)

  • 1. A randomized, double-blind trial of a gonadotropin releasing-hormone agonist (leuprolide) with or without medroxyprogesterone acetate in the treatment of leiomyomata uteri.
    Friedman AJ; Barbieri RL; Doubilet PM; Fine C; Schiff I
    Fertil Steril; 1988 Mar; 49(3):404-9. PubMed ID: 2963759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of leiomyomata with intranasal or subcutaneous leuprolide, a gonadotropin-releasing hormone agonist.
    Friedman AJ; Barbieri RL; Benacerraf BR; Schiff I
    Fertil Steril; 1987 Oct; 48(4):560-4. PubMed ID: 3115833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, placebo-controlled, double-blind study evaluating the efficacy of leuprolide acetate depot in the treatment of uterine leiomyomata.
    Friedman AJ; Harrison-Atlas D; Barbieri RL; Benacerraf B; Gleason R; Schiff I
    Fertil Steril; 1989 Feb; 51(2):251-6. PubMed ID: 2492232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of the effect of gonadotropin-releasing hormone analogs and medroxyprogesterone acetate on uterine leiomyomata volume by magnetic resonance imaging: a prospective, randomized, double blind, placebo-controlled, crossover trial.
    Carr BR; Marshburn PB; Weatherall PT; Bradshaw KD; Breslau NA; Byrd W; Roark M; Steinkampf MP
    J Clin Endocrinol Metab; 1993 May; 76(5):1217-23. PubMed ID: 8496313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of leiomyomata uteri with leuprolide acetate depot: a double-blind, placebo-controlled, multicenter study. The Leuprolide Study Group.
    Friedman AJ; Hoffman DI; Comite F; Browneller RW; Miller JD
    Obstet Gynecol; 1991 May; 77(5):720-5. PubMed ID: 1901638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of leiomyomata uteri with short-term leuprolide followed by leuprolide plus estrogen-progestin hormone replacement therapy for 2 years: a pilot study.
    Friedman AJ
    Fertil Steril; 1989 Mar; 51(3):526-8. PubMed ID: 2537769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fasting serum growth hormone and insulin-like growth factor-I and -II concentrations in women with leiomyomata uteri treated with leuprolide acetate or placebo.
    Friedman AJ; Rein MS; Pandian MR; Barbieri RL
    Fertil Steril; 1990 Feb; 53(2):250-3. PubMed ID: 2105242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, placebo-controlled, double-blind study evaluating leuprolide acetate depot treatment before myomectomy.
    Friedman AJ; Rein MS; Harrison-Atlas D; Garfield JM; Doubilet PM
    Fertil Steril; 1989 Nov; 52(5):728-33. PubMed ID: 2509250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histopathological changes in leiomyomata treated with leuprolide acetate.
    Upadhyaya NB; Doody MC; Googe PB
    Fertil Steril; 1990 Nov; 54(5):811-4. PubMed ID: 2121550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained benefits of leuprolide acetate with or without subsequent medroxyprogesterone acetate in the nonsurgical management of leiomyomata uteri.
    Scialli AR; Jestila KJ
    Fertil Steril; 1995 Aug; 64(2):313-20. PubMed ID: 7615109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective, randomized trial of gonadotropin-releasing hormone agonist plus estrogen-progestin or progestin "add-back" regimens for women with leiomyomata uteri.
    Friedman AJ; Daly M; Juneau-Norcross M; Rein MS; Fine C; Gleason R; Leboff M
    J Clin Endocrinol Metab; 1993 Jun; 76(6):1439-45. PubMed ID: 8501148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A clinical trial of the effects of tibolone administered with gonadotropin-releasing hormone analogues for the treatment of uterine leiomyomata.
    Palomba S; Affinito P; Tommaselli GA; Nappi C
    Fertil Steril; 1998 Jul; 70(1):111-8. PubMed ID: 9660431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized double-blind study evaluating the efficacy on uterine fibroids shrinkage and on intra-operative blood loss of different length of leuprolide acetate depot treatment before myomectomy.
    Jasonni VM; D'Anna R; Mancuso A; Caruso C; Corrado F; Leonardi I
    Acta Obstet Gynecol Scand; 2001 Oct; 80(10):956-8. PubMed ID: 11580742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaginal hemorrhage associated with degenerating submucous leiomyomata during leuprolide acetate treatment.
    Friedman AJ
    Fertil Steril; 1989 Jul; 52(1):152-4. PubMed ID: 2501108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of uterine volume reduction in women with myomas treated with a gonadotropin-releasing hormone agonist.
    Friedman AJ; Daly M; Juneau-Norcross M; Rein MS
    Fertil Steril; 1992 Aug; 58(2):413-5. PubMed ID: 1633911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance imaging of leiomyomata uteri: assessing therapy with the gonadotropin-releasing hormone agonist leuprolide.
    Lubich LM; Alderman MG; Ros PR
    Magn Reson Imaging; 1991; 9(3):331-4. PubMed ID: 1908932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GnRH agonist and iron versus placebo and iron in the anemic patient before surgery for leiomyomas: a randomized controlled trial. Leuprolide Acetate Study Group.
    Stovall TG; Muneyyirci-Delale O; Summitt RL; Scialli AR
    Obstet Gynecol; 1995 Jul; 86(1):65-71. PubMed ID: 7784025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A placebo-controlled trial of a depot gonadotropin-releasing hormone analogue (leuprolide) in the treatment of uterine leiomyomata.
    Schlaff WD; Zerhouni EA; Huth JA; Chen J; Damewood MD; Rock JA
    Obstet Gynecol; 1989 Dec; 74(6):856-62. PubMed ID: 2511532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized trial evaluating leuprolide acetate before hysterectomy as treatment for leiomyomas.
    Stovall TG; Ling FW; Henry LC; Woodruff MR
    Am J Obstet Gynecol; 1991 Jun; 164(6 Pt 1):1420-3; discussion 1423-5. PubMed ID: 1904681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of a gonadotropin-releasing hormone agonist in the treatment of uterine leiomyomata: long-term follow-up.
    Letterie GS; Coddington CC; Winkel CA; Shawker TH; Loriaux DL; Collins RL
    Fertil Steril; 1989 Jun; 51(6):951-6. PubMed ID: 2498132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.